Literature DB >> 24640820

Recent advances in premixed insulin.

Sanjay Kalra.   

Abstract

Premixed biphasic insulin is the most commonly prescribed insulin in Pakistan, as well as in neighbouring countries. This article describes the rationale of using premixed insulin both for initiation and intensification, the evidence in its favour, and the guidelines supporting its use. The review discusses recent advances in the field of premixed insulin, especially insulin degludec aspart combination.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24640820

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  3 in total

1.  Outcomes of transition from premixed and intensive insulin therapies to insulin aspart/degludec co-formulation in type 2 diabetes mellitus: a real-world experience.

Authors:  Serhat Özçelik; Mehmet Çelik; Aşkı Vural; Bünyamin Aydın; Melike Özçelik; Hulya Gozu
Journal:  Arch Med Sci       Date:  2020-02-25       Impact factor: 3.318

2.  Insulin degludec aspart: One-year real world experience.

Authors:  Sanjay Kalra; Manash P Baruah
Journal:  Indian J Endocrinol Metab       Date:  2016 May-Jun

Review 3.  Recombinant Human Insulin in Global Diabetes Management - Focus on Clinical Efficacy.

Authors:  Jean Claude Mbanya; Juergen Sandow; Wolfgang Landgraf; David R Owens
Journal:  Eur Endocrinol       Date:  2017-04-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.